Oxford Global, London, UK
11 - 18 September 2019
Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.
Over 40 presentations and case studies focused on the key issues in Biomanufacturing & Biologics Product Development.
Including 4 interactive streams:
• Biologics Manufacturing, CMC & Continuous Biomanufacturing
• Cell & Gene Therapy Manufacturing: Insights, Key Strategies & Novel Approaches
• Upstream Processing, Digitalisation, Smart Factories, Tools & Technologies
• Downstream Bioprocessing: Recent Technological Advancements and Latest Trends View Agenda - https://bit.ly/2YxhjMo
|
|
|
Invited Speakers:
|
|
Jan Jezek, Chief Scientific Officer, Arecor David Sourdive, Executive Vice President, Technical Operations, Cellectis Daniela Ottini, Vice President, Biologics Manufacturing, AbbVie Murali Bilikallahalli, Vice President & Head of Technical Operations, Acceleron Pharma Stanley Russell, Executive Director, Quality Systems, Standards and Compliance, Alexion Pharmaceuticals Paul Hanson, Senior Director, Technical Operations, Takeda Mark Tomishima, Senior Director, CNS Bioprocess, BlueRock Therapeutics
|
|